Literature DB >> 6461466

Increase of whole-body calcium and skeletal mass in normal and osteoporotic adult rats treated with parathyroid hormone.

E Hefti, U Trechsel, J P Bonjour, H Fleisch, R Schenk.   

Abstract

1. The effect of long-term administration of parathyroid hormone (PTH) on whole-body calcium and ash weight of individual bones has been studied in normal and osteoporotic adult female rats in order to examine whether such a treatment could induce a positive calcium balance. 2. Osteoporosis was induced by calcium restriction during pregnancy and lactation. Sequential measurements of whole-body calcium were made by neutron activation. 3. In non-osteoporotic intact and thyroparathyroidectomized rats a daily dose of 75 units of human PTH 1-34 given subcutaneously for 3 weeks increased whole-body calcium. 4. In osteoporotic animals 25-50 units of either bovine PTH 1-84 or human PTH 1-34 given subcutaneously twice daily for 6 weeks increased both whole-body calcium and ash weight of individual bones. Microradiographic examination of the tibiae indicates, however, that PTH administration does not result in the restoration of individual trabeculae lost during the development of osteoporosis. 5. The results show that PTH can enhance skeletal mass in both normal and osteoporotic rats. In osteoporotic animals the restoration of whole-body calcium and ash weight of individual bones is not accompanied by a return of the morphological structure of the tibia to normal.

Entities:  

Mesh:

Substances:

Year:  1982        PMID: 6461466     DOI: 10.1042/cs0620389

Source DB:  PubMed          Journal:  Clin Sci (Lond)        ISSN: 0143-5221            Impact factor:   6.124


  9 in total

Review 1.  Parathyroid hormone in the treatment of involutional osteoporosis: back to the future.

Authors:  J Y Reginster; A N Taquet; G Fraikin; C Gosset; B Zegels
Journal:  Osteoporos Int       Date:  1997       Impact factor: 4.507

2.  Treatment of postmenopausal osteoporosis with daily parathyroid hormone plus calcitriol.

Authors:  M Neer; D M Slovik; M Daly; T Potts; S R Nussbaum
Journal:  Osteoporos Int       Date:  1993       Impact factor: 4.507

Review 3.  Mechanotransduction and the functional response of bone to mechanical strain.

Authors:  R L Duncan; C H Turner
Journal:  Calcif Tissue Int       Date:  1995-11       Impact factor: 4.333

4.  Effects of combined and separate intermittent administration of low-dose human parathyroid hormone fragment (1-34) and 17 beta-estradiol on bone histomorphometry in ovariectomized rats with established osteopenia.

Authors:  V Shen; D W Dempster; R W Mellish; R Birchman; W Horbert; R Lindsay
Journal:  Calcif Tissue Int       Date:  1992-03       Impact factor: 4.333

5.  Densitometry, radiography, and histological assessment of collagen as methods to evaluate femoral bones in an experimental model of osteoporosis.

Authors:  L Hernandes; A L Ramos; K R Micheletti; A P Santi; O A Cuoghi; M Salazar
Journal:  Osteoporos Int       Date:  2011-02-10       Impact factor: 4.507

6.  Synthetic parathyroid hormone-like protein (1-74) is anabolic for bone in vivo.

Authors:  E C Weir; G Terwilliger; L Sartori; K L Insogna
Journal:  Calcif Tissue Int       Date:  1992-07       Impact factor: 4.333

7.  1,25 dihydroxyvitamin D3 alone or in combination with parathyroid hormone does not increase bone mass in young rats.

Authors:  M Gunness-Hey; I Gera; J Fonseca; L G Raisz; J M Hock
Journal:  Calcif Tissue Int       Date:  1988-11       Impact factor: 4.333

8.  Results of a stimulatory therapy of low bone metabolism in osteoporosis with (1-38)hPTH and diphosphonate EHDP. Protocol of study I, osteoporosis trial Hannover.

Authors:  R D Hesch; J Heck; G Delling; E Keck; J Reeve; H Canzler; O Schober; H Harms; E F Rittinghaus
Journal:  Klin Wochenschr       Date:  1988-10-03

9.  Parathyroid hormone increases the concentration of insulin-like growth factor-I and transforming growth factor beta 1 in rat bone.

Authors:  J Pfeilschifter; F Laukhuf; B Müller-Beckmann; W F Blum; T Pfister; R Ziegler
Journal:  J Clin Invest       Date:  1995-08       Impact factor: 14.808

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.